Mr. Neil Klompas - 09 Oct 2024 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Neil Klompas
Issuer symbol
INM
Transactions as of
09 Oct 2024
Net transactions value
$0
Form type
3
Filing time
17 Oct 2025, 20:33:44 UTC
Previous filing
14 Mar 2023
Next filing
21 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klompas Neil A Director C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA /s/ Neil Klompas 17 Oct 2025 0001761857

No securities are beneficially owned.